The price of Mirena, a hormonal intrauterine device (IUD) manufactured by Bayer, can vary depending on factors such as insurance coverage, pharmacy, and geographic location. While specific pricing details are not publicly disclosed by Bayer, several factors influence the out-of-pocket cost for patients.
What influences Mirena's cost?
The retail price of Mirena can range significantly, often between \$800 and \$1,700 for the device itself. However, this price is frequently offset by insurance. For individuals with insurance, the cost is typically determined by their specific plan's formulary, deductible, copay, or coinsurance. Many insurance plans cover a substantial portion of the IUD cost, or even the full amount, as it is a form of long-acting reversible contraception. For those without insurance or with high-deductible plans, the cost can be higher. Additionally, the professional fee for insertion and removal by a healthcare provider is a separate cost that also varies.
How does insurance coverage work for Mirena?
Under the Affordable Care Act (ACA), most health insurance plans are required to cover preventive services, including contraception like Mirena, without cost-sharing. This means that if a plan is ACA-compliant, patients may pay nothing for the device and its insertion if it's prescribed for contraception. However, coverage can differ for plans that are not ACA-compliant, such as grandfathered plans or certain short-term health insurance policies. It is advisable for individuals to verify their specific coverage with their insurance provider before obtaining Mirena.
Can I get financial assistance for Mirena?
Bayer offers patient assistance programs that may help reduce the cost of Mirena for eligible individuals who are uninsured or underinsured. These programs can provide financial support or discounts on the medication. Details about these programs and eligibility criteria are typically available through Bayer's official website or by speaking with a healthcare provider or pharmacist.
When does Mirena's patent expire?
Information regarding the specific patent expiration dates for Mirena is available through resources like DrugPatentWatch.com. Patent exclusivity periods determine how long a drug manufacturer has exclusive rights to sell a product. Once patents expire, generic or biosimilar versions may become available, potentially leading to lower prices [1]. DrugPatentWatch.com provides detailed patent information for pharmaceutical products.
Who are Mirena's main competitors?
Mirena competes with other long-acting reversible contraceptives (LARCs), including other hormonal IUDs, non-hormonal IUDs, and contraceptive implants. Other hormonal IUDs available in some markets include Kyleena, Liletta, and Skyla, which may differ in hormone dosage, duration of use, and size [2]. Non-hormonal IUDs, such as ParaGard, are also an alternative for individuals seeking contraception without hormones.
What is the clinical data supporting Mirena's use?
Clinical studies have demonstrated Mirena's high efficacy in preventing pregnancy. It is more than 99% effective, meaning fewer than 1 out of 100 people using Mirena become pregnant each year. Mirena is approved for use for up to eight years for prevention of pregnancy [3]. It is also indicated for heavy menstrual bleeding in women who choose intrauterine contraception [3].
What are potential side effects of Mirena?
Common side effects associated with Mirena include changes in menstrual bleeding patterns (such as spotting, irregular bleeding, or heavier bleeding), ovarian cysts, and pelvic pain [3]. Less common but more serious risks can include perforation of the uterus, expulsion of the IUD, or pelvic inflammatory disease. Healthcare providers discuss these risks with patients prior to insertion.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.plannedparenthood.org/learn/birth-control/iud
[3] https://www.mirena-us.com/